【研究报告】2022年癌胚抗原(CEA)市场规模为214136万美元,预计到2030年将达到347594万美元;预计 2022 年至 2030 年复合年增长率为 6.2。
市场洞察和分析师观点: strong>
癌胚抗原是指一组在细胞粘附中发挥作用的糖蛋白。 CEA 通常在胎儿胃肠组织中产生,但产生在出生前终止。因此,通常可以在健康人的血液中检测到低浓度的 CEA。 CEA 也称为肿瘤标志物或肿瘤抗原。肿瘤标志物是许多癌细胞产生的物质,有时会泄漏到生理液中。 CEA 检测可检测血液或其他体液中是否存在癌胚抗原(一种肿瘤标志物)。
推动癌胚抗原 (CEA) 市场增长的关键因素包括患病率不断增加癌症的发病率、老年人口的增加以及对微创诊断程序的需求不断增加。然而,CEA 对早期肿瘤癌症的无效检测阻碍了市场增长。
增长驱动因素和限制:
癌症是全球主要的健康挑战之一,其发病率在全球范围内不断增加。有几个因素导致癌症病例增加,包括生活方式的改变、环境因素和人口老龄化。全球各地的医疗机构都发现癌症患病率大幅上升。据美国国家癌症研究所 (NCI) 称,癌症日益成为一个全球健康问题。 2021年,全球新增癌症病例超过1930万,导致约1000万人因癌症相关死亡。世界卫生组织估计,到 2040 年,全球可能会新增 2890 万癌症病例,每年约有 1620 万癌症相关死亡病例。 CEA 是一种生物标志物,常用于监测和诊断各种类型的癌症,包括肺癌、结直肠癌和乳腺癌。癌症发病率的不断上升刺激了对 CEA 检测的需求,从而推动了 CEA 市场的增长。
全球范围内由 65 岁及以上人群组成的老年人口正在增加。根据国际癌症控制联盟(UICC)的说法,衰老是癌症的一个重要危险因素,老年人的癌症发病率更高。据世界卫生组织 (WHO) 预测,2015 年至 2050 年间,全球 60 岁以上人口比例将增加近一倍,从 12% 增至 22%。随着老年人口的增长,对癌症筛查、诊断和监测的需求也随之增加。 CEA检测在老年人癌症管理中发挥着至关重要的作用,有助于早期发现、治疗监测和疾病监测。
此外,诊断检测技术的进步提高了准确性以及 CEA 测试的效率。免疫测定和分子诊断等较新的检测技术提高了 CEA 检测的灵敏度和特异性。这些进步使得癌症诊断更早、更准确,并更好地监测治疗反应。改进的测试技术的出现有助于扩大 CEA 市场。此外,各国政府、医疗保健组织和癌症协会一直在积极推动癌症筛查计划,并提高人们对及时发现癌症重要性的认识。这些举措旨在教育大众了解定期筛查的好处,并鼓励个人接受适当的诊断测试,包括 CEA 测试。筛查计划和意识举措的实施有助于 CEA 市场的整体增长。因此,癌症发病率的增加、老年人口的增长、对早期检测和监测的重视、检测技术的进步以及癌症筛查计划和宣传举措是 CEA 市场增长的关键驱动力。这些因素凸显了CEA检测在癌症诊断、治疗监测和疾病监测中的重要性,从而推动了对CEA检测产品和服务的需求。
而癌胚抗原(CEA)尽管 CEA 检测广泛用于诊断应用和监测癌症,如肺癌、乳腺癌和结直肠癌,但必须注意的是,CEA 检测具有局限性,特别是在检测早期肿瘤的有效性方面。 CEA 检测对于癌症的早期检测并不具有高度敏感性或特异性。敏感性是指测试正确识别患有该病症的个体的能力,而特异性是指测试正确识别没有该病症的个体的能力。 CEA 水平在其他非癌症疾病中也会升高,例如肝病、吸烟和炎症性肠病。因此,CEA检测可能会产生假阳性或假阴性结果,导致其早期肿瘤检测的有效性受到限制。
CEA检测对早期肿瘤检测的敏感性较低阶段肿瘤与其在监测癌症进展或复发中的效用进行比较。在癌症的早期阶段,CEA 水平可能保持在正常范围内,从而使其对早期肿瘤检测的效果较差。其他筛查方法,例如成像技术(例如乳房X光检查、结肠镜检查)和基因检测,对于检测早期肿瘤通常更可靠。
< u>战略见解
报告细分和范围:
全球癌胚抗原 (CEA) 市场根据测试类型、应用、最终用途和地理位置进行分类。根据测试类型,癌胚抗原 (CEA) 市场分为 ELISA、放射免疫分析 (RIA)、荧光免疫分析 (FIA) 等。根据应用,癌胚抗原(CEA)分为结直肠癌、胰腺癌、乳腺癌、肺癌等。根据最终用途,市场分为医院、诊断中心以及研究和学术机构。癌胚抗原(CEA)市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和美国非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。
细分分析:< /span>
癌胚抗原 (CEA) 市场按测试类型分为 ELISA、放射免疫分析 (RIA)、荧光免疫分析 (FIA) 等。 ELISA 细分市场在 2022 年占据最大的癌胚抗原 (CEA) 市场份额,预计 2022-2030 年市场复合年增长率最高。酶联免疫吸附测定 (ELISA) 通常用于测量生物样品中的抗体、抗原、蛋白质和糖蛋白。 CEA 市场中的 ELISA 部分在各种临床环境中 CEA 水平的检测、定量和监测中发挥着至关重要的作用。该技术的高灵敏度、特异性和广泛的自动化能力使其在 CEA 测试中占据突出地位。
按测试类型划分的癌胚抗原 (CEA) 市场; – 2022年和2030年
根据申请情况, ;癌胚抗原(CEA)市场分为结直肠癌、胰腺癌、乳腺癌、肺癌等。结直肠细分市场在 2022 年占据最大的癌胚抗原 (CEA) 市场份额。然而,预计乳腺细分市场在 2022 年至 2030 年期间的复合年增长率最高。
根据最终用途,癌胚抗原(CEA)市场分为医院、诊断中心以及研究和学术机构。 2022年,医院细分市场拥有最大的癌胚抗原(CEA)市场。然而,研究和学术机构细分市场预计在2022-2030年期间将实现最高的复合年增长率。
< span>区域分析:
根据地理位置,全球癌胚抗原 (CEA) 市场分为五个主要区域地区:北美、欧洲、亚太地区、南美洲和南美洲中美洲、中东和非洲非洲。由于人口老龄化加剧、癌症患病率上升以及医疗保健成本上升,亚太地区预计 2022 年至 2030 年复合年增长率最高。尖端医疗基础设施的发展以及癌症筛查和早期诊断意识的提高都推动了该地区对 CEA 检测的需求。亚太地区 CEA 市场收入的增长得益于庞大的患者群体和对尖端诊断技术接受度的提高。
2022 年,北美占据最大份额全球癌胚抗原(CEA)市场规模。美国的癌症发病率很高,这推动了癌胚抗原(CEA)市场的增长。据美国癌症协会估计,2021年有超过190万人被诊断出患有癌症,608,570人因癌症死亡。另据报道,在美国,有二分之一的男性和三分之一的女性在一生中会被诊断出患有癌症。因此,美国人癌症的高患病率推动了癌胚抗原(CEA)市场的增长。
此外,根据美国医疗保险和癌症中心的数据,医疗补助服务,2021 年美国国家医疗保健支出增长 2.7%,达到 4.3 万亿美元,即人均 12,914 美元。此外,医疗支出占国内生产总值的18.3%。此外,根据美国卫生部的数据,人类服务方面,2021年至2031年,国家卫生支出预计将以年均5.4%的速度增长,到2031年预计将达到6.2万亿美元。不断增长的卫生支出预计将增加与卫生保健相关的研究的各种资金投入。药物的开发,推动了研究和学术机构对癌胚抗原(CEA)的需求。
行业发展和未来机遇:
全球癌胚抗原 (CEA) 市场主要参与者采取的各种举措如下:
- 2023 年 8 月,安捷伦科技公司在马来西亚莫纳什大学开设了一个新的全规模综合生物中心。它的重点是建设当地能力,以加速科学领域的研究和开发。
- 2023 年 5 月,辉瑞和 Thermo Fisher Scientific Inc. 签订了一项合作协议,以帮助增加当地获得药物的机会为拉丁美洲、非洲、中东和亚洲 30 多个国家的肺癌和乳腺癌患者提供基于下一代测序 (NGS) 的检测,这些国家的高级基因组检测以前受到限制或不可用。获得本地 NGS 测试有助于更快地分析相关基因,从而使医疗保健提供者能够为特定患者选择最佳药物。
- 2023 年 1 月,全球领先的赛默飞世尔科技公司服务科学,以全现金交易从 Nordic Capital 领导的股东集团手中完成了对专业诊断领域全球领导者 The Binding Site Group 的收购,交易价值为 23 亿英镑(按当前汇率计算为 28 亿美元)。 Binding Site 为现有的专业诊断产品组合增添了多发性骨髓瘤诊断和监测方面的开创性创新。早期检测和明智的治疗决策可以极大地影响患者的治疗结果。
竞争格局和主要公司:
Abbott Laboratories、F. Hoffmann-La Roche Ltd、Quest Diagnostics Incorporated、RayBiotech Inc、Prospec-Tany Technogene Ltd、Agilent Technologies Inc、GenWay Biotech Inc、Merck KGaA、Lee BioSolutions 和 Thermo Fisher Scientific 是癌胚抗原 (CEA) 市场的知名参与者之一。这些公司专注于新技术、现有产品的进步和地域扩张,以满足全球不断增长的消费者需求并扩大其专业产品组合的产品范围。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
- F. Hoffmann-La Roche Ltd
- Abbott
- Quest Diagnostics Incorporated
- RayBiotech, Inc.
- Prospec-Tany Technogene Ltd
- Correlogic Systems, Inc
- GenWay Biotech Inc
- Merck KGaA
- Lee BioSolutions
- Cigna
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.